Induction of tolerance to CNS autoantigens by genetic and cellular engineering

  • Siatskas, Christopher (Primary Chief Investigator (PCI))
  • Bernard, Claude (Chief Investigator (CI))
  • Boyd, Richard (Partner Investigator (PI))

    Project: Research

    Project Details

    StatusFinished
    Effective start/end date1/01/11 → 31/12/13

    Funding

    • Multiple Sclerosis Research Australia (trading as National Multiple Sclerosis Research Foundation Limited): A$95,000.00
    • Multiple Sclerosis Research Australia (trading as National Multiple Sclerosis Research Foundation Limited): A$195,000.00